Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 32, Issue 1, 2001, Pages 64-69

  Pattanapanyasat, Kovit ^a,e   Kotipun, Kitchaporn ^b   Yongvanitchit, Kosol ^c   Hider, Robert C ^d   Kyle, Dennis E ^c   Heppner, D Gray ^c   Walsh, Douglas S ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Charoen Krung Pracharak Hospital   (Thailand)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; IRON CHELATING AGENT; PYRIDONE DERIVATIVE;

ANIMAL; ARTICLE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IN VITRO STUDY; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; IRON CHELATING AGENTS; PLASMODIUM FALCIPARUM; PYRIDONES;

EID: 0035291604     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Basco LK, Le Bras J. In vitro activity of chloroquine and quinine in combination with desferrioxamine agaist Plasmodium falciparum. Am J Hematol 1993; 42: 389-91.
2. Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis 1978; 137: 122-30.
3. Bunnag D, Poltera AA, Viravan C, Looareesuwan S, Harinasuta KY, Schindlery C. Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria for Thailand. Acta Tropica 1992; 52: 59-67.
4. Dobbin PS, Hider HC, Hall AD, et al. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: Orally active iron chelators with clinical potential. J Med Chem 1993; 36: 2448-58.
5. Gordeuk VR, Thuma PE, Brittenham GM, et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 1992a; 327: 1473-7.
6. Gordeuk VR, Thuma PE, Brittenham GM, et al. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood 1992b; 79: 308-12.
7. Gordeuk VR, Thuma PE, Brittenham GM, et al. Iron chelation as a chemotherapeutic strategy for falciparum malaria. Am J Trop Med Hyg 1993; 48: 193-7.
8. Harvey PWJ, Heywood PF, Nesheim MC, et al. The effect of iron therapy on malarial infection in Papua New Guinean school children. Am J Trop Med Hyg 1989; 40: 12-8.
9. Heppner DG, Hallaway PE, Kontoghiorghes GJ, Eaton JW. Antimalarial properties of orally active iron chelators. Blood 1988; 72: 358-61.
10. Hershko C, Theanacho EN, Spira DT, Peter HH, Dobbin P, Hider RC. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. Blood 1991;77:637-43.
11. Kamchonwongpaisan S, Vanitcharoen N, Yuthavong Y. The mechanism of action of artemisinin (qinghaosu). In: Ong ASH, Parker L, eds. Lipid-Soluble Antioxidant: Biochemistry and Clinical Applications. Basel: Birkhauser-Vertlag, 1992: 363-72.
12. Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979; 65: 418-20.
13. Lederman HM, Cohen A, Lee JWW, Freidman MH, Gelfand EW. Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation. Blood 1984; 64: 748-53.
14. Mastrardrea S, Carvajal JL, Kaeda JS, et al. Growth inhibition of Plasmodium falciparum by orally active iron chelators. Drugs of Today 1992; 28: 25-7.
15. Meshnick SR, Tsang TW, Lin FB, et al. Activated oxygen mediates the antimalarial activity of qinhausu. Prog Clin Biol Res 1989; 313: 95-104.
16. Meshnick SR, Yang Y-Z, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y. Iron-Dependent free radical generation from the antimalarial agent artemisinin (qinhaosu). Antimicrob Agents Chemother 1993; 37: 1108-14.
17. Murray MJ, Murray AB, Murray MB, Murray CJ. The adverse effect of iron repletion on the course of certain infections. Br Med J 1983; 2: 1113-5.
18. Nyholm S, Mann GJ, Johansson AG, Bergeron RJ, Graslund A, Thelander L. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators. J Biol Chem 1993; 268: 26200-5.
19. Oppenheimer SJ, Gibson FD, Macfarlane SB, et al. Iron supplementation increases prevalence and effects of malaria: Report on clinical studies in Papua New Guinea. Trans R Soc Trop Med Hyg 1986; 80: 603-12.
20. Pattanapanyasat K, Thaithong S, Kyle DE, et al. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria. Cytometry 1997; 27: 84-91.
21. Pattanapanyasat K, Webster HK, Tongtawe P, Kongcharoen P, Hider RC. Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function. Br J Haematol 1992; 82: 13-9.
22. Posner GH, Cumming JN, Ploypradith P, Oh CH. Evidence for Fe(IV)=O in the molecular mechanism of action of the trioxane antimalarial artemisinin. J Am Chem Soc 1995; 117: 5885-7.
23. Posner GH, Oh CH. A radiospecifically oxygen-18 labeled 1,2,4-trioxane: A simple chemical model system to probe the mechanism(s) for the antimalarial activity of artemisinin (qinhaosu). J Am Chem Soc 1992; 114: 8328-9.
24. Raventos-Suarez C, Pollack S, Nagel RL. Plasmodium falciparum: Inhibition of in vitro growth by desferrioxamine. Am J Trop Med Hyg 1982; 31: 919-22.
25. Traore O, Carnevale P, Kaptue NL, et al. Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. Am J Hematol 1991; 37: 206-8.
26. van Zyl RL, Havlik I, Monteaagudo FSE. The combined effect of iron chelators and classical antimalarials on the in vitro growth of Plasmodium falciparum. J Antimicrob Chemother 1992; 30: 273-8.
27. Webster HK, Boudreau EF, Pavanand K, Yongvanitchit K, Pang LW. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg 1985; 34: 228-35.
28. Zhang F, Gosser D, Meshnick SR. Hemin-catalyzed decomposition of artemisinin (qinhaosu). Biochem Pharmacol 1992; 43: 1805-9.